Cargando…
Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity
BACKGROUND: Chagas disease, also known as American Trypanosomiasis, is caused by the protozoan Trypanosoma cruzi. It is occurring in Americas, including USA and Canada, and Europe and its current treatment involves the use of two drugs as follows: benznidazole (BNZ) and nifurtimox, which present hig...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026134/ https://www.ncbi.nlm.nih.gov/pubmed/32103950 http://dx.doi.org/10.2147/IJN.S216386 |
_version_ | 1783498627935633408 |
---|---|
author | Brito, Talita Katiane Silva Viana, Rony Lucas Gonçalves Moreno, Cláudia Jassica da Silva Barbosa, Jefferson Lopes de Sousa Júnior, Francimar Campos de Medeiros, Mayara Jane Melo-Silveira, Raniere Fagundes Almeida-Lima, Jailma de Lima Pontes, Daniel Sousa Silva, Marcelo Oliveira Rocha, Hugo Alexandre |
author_facet | Brito, Talita Katiane Silva Viana, Rony Lucas Gonçalves Moreno, Cláudia Jassica da Silva Barbosa, Jefferson Lopes de Sousa Júnior, Francimar Campos de Medeiros, Mayara Jane Melo-Silveira, Raniere Fagundes Almeida-Lima, Jailma de Lima Pontes, Daniel Sousa Silva, Marcelo Oliveira Rocha, Hugo Alexandre |
author_sort | Brito, Talita Katiane |
collection | PubMed |
description | BACKGROUND: Chagas disease, also known as American Trypanosomiasis, is caused by the protozoan Trypanosoma cruzi. It is occurring in Americas, including USA and Canada, and Europe and its current treatment involves the use of two drugs as follows: benznidazole (BNZ) and nifurtimox, which present high toxicity and low efficacy during the chronic phase of the disease, thus promoting the search for more effective therapeutic alternatives. Amongst them xylan, a bioactive polysaccharide, extracted from corn cob. METHODS: Ultraviolet-visible spectroscopy, Fourier transform infrared spectroscopy (FITR), Raman spectroscopy, energy-dispersive X-ray spectroscopy (EDS), scanning electron microscopy, atomic force microscopy, plasma optical emission spectroscopy (ICP-OES), dynamic light scattering (DLS) have been used to characterize the silver-xylan nanoparticles (NX). Their cytotoxicity was evaluated with 3-bromo(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) test. MTT and flow cytometry were used to ascertain the anti-Trypanosoma cruzi activity. RESULTS: UV-Vis spectroscopy gave plasmon resonance ranging between 400 and 450 nm while FITC and Raman spectroscopy proved nano interface functionalized with xylan. ICP-OES data showed NX with xylan (81%) and silver (19%). EDS showed NX consisting of carbon (59.4%), oxygen (26.2%) and silver (4.8%) main elements. Spherical NX of 55 nm average size has been depicted with SEM and AFM, while DLS showed 102 ± 1.7 nm NX. The NX displayed negligible cytotoxicity (2000 µg/mL). NX (100 µg/mL) was more effective, regardless of experiment time, in affecting the ability of parasites to reduce MTT than BZN (100 µg/mL). In addition, NX (100 µg/mL) induced death of 95% of parasites by necrosis. CONCLUSION: This is the first time silver nanoparticles are presented as an anti-Trypanosoma cruzi agent and the data point to the potential application of NX to new preclinical studies in vitro and in vivo. |
format | Online Article Text |
id | pubmed-7026134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-70261342020-02-26 Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity Brito, Talita Katiane Silva Viana, Rony Lucas Gonçalves Moreno, Cláudia Jassica da Silva Barbosa, Jefferson Lopes de Sousa Júnior, Francimar Campos de Medeiros, Mayara Jane Melo-Silveira, Raniere Fagundes Almeida-Lima, Jailma de Lima Pontes, Daniel Sousa Silva, Marcelo Oliveira Rocha, Hugo Alexandre Int J Nanomedicine Original Research BACKGROUND: Chagas disease, also known as American Trypanosomiasis, is caused by the protozoan Trypanosoma cruzi. It is occurring in Americas, including USA and Canada, and Europe and its current treatment involves the use of two drugs as follows: benznidazole (BNZ) and nifurtimox, which present high toxicity and low efficacy during the chronic phase of the disease, thus promoting the search for more effective therapeutic alternatives. Amongst them xylan, a bioactive polysaccharide, extracted from corn cob. METHODS: Ultraviolet-visible spectroscopy, Fourier transform infrared spectroscopy (FITR), Raman spectroscopy, energy-dispersive X-ray spectroscopy (EDS), scanning electron microscopy, atomic force microscopy, plasma optical emission spectroscopy (ICP-OES), dynamic light scattering (DLS) have been used to characterize the silver-xylan nanoparticles (NX). Their cytotoxicity was evaluated with 3-bromo(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) test. MTT and flow cytometry were used to ascertain the anti-Trypanosoma cruzi activity. RESULTS: UV-Vis spectroscopy gave plasmon resonance ranging between 400 and 450 nm while FITC and Raman spectroscopy proved nano interface functionalized with xylan. ICP-OES data showed NX with xylan (81%) and silver (19%). EDS showed NX consisting of carbon (59.4%), oxygen (26.2%) and silver (4.8%) main elements. Spherical NX of 55 nm average size has been depicted with SEM and AFM, while DLS showed 102 ± 1.7 nm NX. The NX displayed negligible cytotoxicity (2000 µg/mL). NX (100 µg/mL) was more effective, regardless of experiment time, in affecting the ability of parasites to reduce MTT than BZN (100 µg/mL). In addition, NX (100 µg/mL) induced death of 95% of parasites by necrosis. CONCLUSION: This is the first time silver nanoparticles are presented as an anti-Trypanosoma cruzi agent and the data point to the potential application of NX to new preclinical studies in vitro and in vivo. Dove 2020-02-12 /pmc/articles/PMC7026134/ /pubmed/32103950 http://dx.doi.org/10.2147/IJN.S216386 Text en © 2020 Brito et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Brito, Talita Katiane Silva Viana, Rony Lucas Gonçalves Moreno, Cláudia Jassica da Silva Barbosa, Jefferson Lopes de Sousa Júnior, Francimar Campos de Medeiros, Mayara Jane Melo-Silveira, Raniere Fagundes Almeida-Lima, Jailma de Lima Pontes, Daniel Sousa Silva, Marcelo Oliveira Rocha, Hugo Alexandre Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity |
title | Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity |
title_full | Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity |
title_fullStr | Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity |
title_full_unstemmed | Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity |
title_short | Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity |
title_sort | synthesis of silver nanoparticle employing corn cob xylan as a reducing agent with anti-trypanosoma cruzi activity |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026134/ https://www.ncbi.nlm.nih.gov/pubmed/32103950 http://dx.doi.org/10.2147/IJN.S216386 |
work_keys_str_mv | AT britotalitakatiane synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT silvavianaronylucas synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT goncalvesmorenoclaudiajassica synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT dasilvabarbosajefferson synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT lopesdesousajuniorfrancimar synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT camposdemedeirosmayarajane synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT melosilveiraranierefagundes synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT almeidalimajailma synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT delimapontesdaniel synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT sousasilvamarcelo synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity AT oliveirarochahugoalexandre synthesisofsilvernanoparticleemployingcorncobxylanasareducingagentwithantitrypanosomacruziactivity |